 |
|
The management of post-transplantation recurrence of hepatocellular carcinoma
Luckshi Rajendran, Tommy Ivanics, Marco PAW Claasen, Hala Muaddi, Gonzalo Sapisochin
Clin Mol Hepatol. 2022;28(1):1-16. Published online 2021 Oct 5 DOI: https://doi.org/10.3350/cmh.2021.0217
|
|
Citations to this article as recorded by
 2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III Recommendations
Ashish Kumar, Subrat K. Acharya, Shivaram P. Singh, Ajay Duseja, Kaushal Madan, Akash Shukla, Anil Arora, Anil C. Anand, Ankur Bahl, Arvinder S. Soin, Bhawna Sirohi, Debnarayan Dutta, Dinesh Jothimani, Dipanjan Panda, Gagan Saini, Joy Varghese, Karan Kuma
Journal of Clinical and Experimental Hepatology.2024; 14(1): 101269. CrossRef Three molecular subtypes and a five‐gene signature for hepatocellular carcinoma based on m7G‐related classification
Yuan Yue, Jie Tao, Dan An, Lei Shi
The Journal of Gene Medicine.2024;[Epub] CrossRef Sorafenib for 9,923 Patients with Hepatocellular Carcinoma: An Analysis from National Health Insurance Claim Data in South Korea
Sojung Han, Do Young Kim, Ho Yeong Lim, Jung-Hwan Yoon, Baek-Yeol Ryoo, Yujeong Kim, Kookhee Kim, Bo Yeon Kim, So Young Yi, Dong-Sook Kim, Do-Yeon Cho, Jina Yu, Suhyun Kim, Joong-Won Park
Gut and Liver.2024; 18(1): 116. CrossRef A Lactic Acid Metabolism-Related Gene Signature for Predicting Clinical Outcome and Tumor Microenvironmental Status in Patients with Hepatocellular Carcinoma
Zhongcheng Zhou, Bin Wu, Jing Chen, Yiyu Shen, Jing Wang, Xujian Chen, Faming Fei, Mingyuan Zhu
Nutrition and Cancer.2024; 76(3): 279. CrossRef Association between Unplanned Conversion and Patient Survival after Laparoscopic Liver Resection for Hepatocellular Carcinoma: A Propensity Score Matched Analysis
Boram Lee, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, MeeYoung Kang, Yeshong Park, Jinju Kim
Journal of Clinical Medicine.2024; 13(4): 1116. CrossRef Indication of Liver Transplant for HCC: Current Status and Future Directions
Julian K. Horwitz, Vatche G. Agopian
Current Hepatology Reports.2024; 23(1): 185. CrossRef Exploring the metastasis-related biomarker and carcinogenic mechanism in liver cancer based on single cell technology
Qiuxiang Zheng, Cuiping Lu, Lian Yu, Ying Zhan, Zhiyong Chen
Heliyon.2024; 10(6): e27473. CrossRef Achieving Textbook Outcomes after Laparoscopic Resection in Posterosuperior Segments of the Liver: The Impact of the Learning Curve
Mizelle D’Silva, Jai-Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae-Won Lee, Bo-Ram Lee, Mee-Young Kang, Ye-Shong Park, Jin-Ju Kim
Cancers.2024; 16(5): 930. CrossRef Rapamycin inhibits B16 melanoma cell viability in vitro and in vivo by inducing autophagy and inhibiting the mTOR/p70‑S6k pathway
Penghui Wang, Haifang Zhang, Kaikai Guo, Chun Liu, Shimin Chen, Baopeng Pu, Sirun Chen, Tong Feng, Hanyi Jiao, Chang Gao
Oncology Letters.2024;[Epub] CrossRef Commentary: Case Report: Lenvatinib for the treatment of recurrent hepatocellular carcinoma in people living with HIV: a report of two cases
Cuiming Sun, Ying Wen, Jin Zhou
Frontiers in Oncology.2024;[Epub] CrossRef A mixed blessing for liver transplantation patients — Rapamycin
Guang-Han Fan, Chen-Zhi Zhang, Feng-Qiang Gao, Xu-Yong Wei, Sun-Bin Ling, Kai Wang, Jian-Guo Wang, Shu-Sen Zheng, Mehrdad Nikfarjam, Xiao Xu
Hepatobiliary & Pancreatic Diseases International.2023; 22(1): 14. CrossRef Sorafenib versus nivolumab after lenvatinib treatment failure in patients with advanced hepatocellular carcinoma
Yuna Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Myung Ji Goh, Wonseok Kang, Seung Up Kim
European Journal of Gastroenterology & Hepatology.2023; 35(2): 191. CrossRef Immunotherapy for Hepatocellular Carcinoma in the Setting of Liver Transplantation: A Review
Zurabi Lominadze, Kareen Hill, Mohammed Rifat Shaik, Justin P. Canakis, Mohammad Bourmaf, Cyrus Adams-Mardi, Ameer Abutaleb, Lopa Mishra, Kirti Shetty
International Journal of Molecular Sciences.2023; 24(3): 2358. CrossRef Main factors influencing long-term outcomes of liver transplantation in 2022
Elisa Fuochi, Lorenzo Anastasio, Erica Nicola Lynch, Claudia Campani, Gabriele Dragoni, Stefano Milani, Andrea Galli, Tommaso Innocenti
World Journal of Hepatology.2023; 15(3): 321. CrossRef Plumbagin Exhibits Genotoxicity and Induces G2/M Cell Cycle Arrest via ROS-Mediated Oxidative Stress and Activation of ATM-p53 Signaling Pathway in Hepatocellular Cells
Huan Liu, Wenchao Zhang, Lijie Jin, Shasha Liu, Liying Liang, Yanfei Wei
International Journal of Molecular Sciences.2023; 24(7): 6279. CrossRef Microwave Ablation of Recurrent Hepatocellular Carcinoma after Curative Surgical Resection
Hamzah Adwan, Lars Hammann, Thomas J. Vogl
Journal of Clinical Medicine.2023; 12(7): 2560. CrossRef An Analysis Regarding the Association Between Proteasome (PSM) and Hepatocellular Carcinoma (HCC)
Wei Huang, Jia Mei, Yuan-Jie Liu, Jie-Pin Li, Xi Zou, Xiao-Ping Qian, Yu Zhang
Journal of Hepatocellular Carcinoma.2023; Volume 10: 497. CrossRef LI-RADS Morphological Type Predicts Prognosis of Patients with Hepatocellular Carcinoma After Radical Resection
Chunhui Zhang, Rui Yang, Xinxin Wang, Yuqing Tao, Shuli Tang, Zhennan Tian, Yang Zhou
Annals of Surgical Oncology.2023; 30(8): 4876. CrossRef The Role of mTOR Inhibitors after Liver Transplantation for Hepatocellular Carcinoma
Letizia Todeschini, Luca Cristin, Alessandro Martinino, Amelia Mattia, Salvatore Agnes, Francesco Giovinazzo
Current Oncology.2023; 30(6): 5574. CrossRef High expression of GPR50 promotes the proliferation, migration and autophagy of hepatocellular carcinoma cells in vitro
Weiming Zhao, Lingling Xi, Guoying Yu, Gaiping Wang, Cuifang Chang
Journal of Cell Communication and Signaling.2023; 17(4): 1435. CrossRef SEER-based risk stratification system for patients with primary non-cirrhotic liver cancer
Runmin Cao, Honghe Jiang, Guangpeng Liang, Weibin Zhang
Journal of Cancer Research and Clinical Oncology.2023; 149(13): 12033. CrossRef Sequencing Systemic Therapy in Hepatocellular Carcinoma
Ben Ponvilawan, Marc T. Roth
Current Treatment Options in Oncology.2023; 24(11): 1580. CrossRef The current role of radiofrequency ablation in the treatment of intrahepatic recurrent hepatocellular carcinoma
Rong Fu, Wenwu Ling
Journal of Surgical Oncology.2023; 128(8): 1340. CrossRef Sequential regorafenib or nivolumab therapy in recurrent hepatocellular carcinoma with sorafenib failure in liver transplant patients does not improve prognosis
Jieun Kwon, Jongman Kim, Jinsoo Rhu, Gyu-Seong Choi, Jae-Won Joh
Annals of Liver Transplantation.2023; 3(2): 104. CrossRef Postoperative adjuvant immunotherapy for high-risk hepatocellular carcinoma patients
Wei-Qiao Zhang, Qiao Zhang, Li Tan, Zhi-Feng Guan, Feng Tian, Hong-Tao Tang, Kun He, Wei-Qiang Chen
Frontiers in Oncology.2023;[Epub] CrossRef Prediction models of hepatocellular carcinoma recurrence after liver transplantation: A comprehensive review
Sang Jin Kim, Jong Man Kim
Clinical and Molecular Hepatology.2022; 28(4): 739. CrossRef Delayed Hepatocellular Carcinoma Recurrence After Liver Transplantation: Comprehensive Clinical Characterization of Case Series
Ta-Hsiang Wong, Cheng-Maw Ho, Hsao-Hsun Hsu, Yao-Ming Wu, Ming-Chih Ho, Po-Huang Lee, Rey-Heng Hu
Journal of Hepatocellular Carcinoma.2022; Volume 9: 1081. CrossRef
|